Oral Metronomic Chemotherapy in Recurrent, Metastatic and Locally Advanced Head and Neck Cancers

Clinical Oncology

Volumn 25, Issue 6, 2013, Pages 388-

  Patil, V ^a   Noronha, V ^a   Krishna, V ^a   Joshi, A ^a   Prabhash, K ^a  

^a TMH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; HEAD AND NECK CANCER; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, METRONOMIC; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; METHOTREXATE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PYRAZOLES; SULFONAMIDES;

EID: 84877143685     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.01.002     Document Type: Letter

References (5)

1. Specenier P.M., Vermorken J.B. Recurrent head and neck cancer: current treatment and future prospects. Expert Rev Anticancer Ther 2008, 8(3):375-391.
2. Price K.A.R., Cohen E.E. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol 2012, 13(1):35-46.
3. Vermorken J.B., Mesia R., Rivera F., et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008, 359(11):1116-1127.
4. Lin D.T., Subbaramaiah K., Shah J.P., Dannenberg A.J., Boyle J.O. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 2002, 24(8):792-799.
5. Pathak K.A., Juvekar A.S., Radhakrishnan D.K., et al. In vitro chemosensitivity profile of oral squamous cell cancer and its correlation with clinical response to chemotherapy. Indian J Cancer 2007, 44(4):142-146.